AI-Powered Digital Pathology Diagnostics Market
完整報告名稱與涵蓋範圍
AI-Powered Digital Pathology Diagnostics Market Size, Share & Trends Analysis Report, By Software Type (Cancer Detection, Grading and Screening Algorithms, Biomarker Quantification and Companion Diagnostic AI, Quality Control, Triage and Workflow Prioritization Tools, Foundation Models and Multimodal Pathology Platforms), By Application (Prostate, Breast and Gastrointestinal Cancer Diagnosis, Immunohistochemistry and Biomarker Scoring, Hematopathology, Cytology and Other Specialties, Drug Development and Clinical Trial Analysis), By Deployment (Cloud-Based, On-Premise and Scanner-Integrated), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The AI-powered digital pathology diagnostics market covers algorithms and platforms that analyse whole slide images to detect, grade and screen cancer, quantify biomarkers and support companion diagnostics, triage and prioritise workflow and, increasingly, apply foundation models across tissue types, deployed in clinical laboratories and pharmaceutical research. Whole slide scanners and image management systems are covered in the digital pathology study and excluded here.
The category has matured from research tools to cleared clinical software, with prostate biopsy detection and breast biomarker scoring among the first approved applications and a growing number of algorithms available through open platforms integrated with scanner and image management ecosystems. Adoption is driven by pathologist shortages, the need for reproducible biomarker quantification for targeted therapies, quality assurance and the promise of foundation models trained on millions of slides that generalise across cancers and predict molecular status and outcomes. Pharmaceutical companies use AI pathology for trial enrichment, biomarker discovery and companion diagnostic development, while laboratories require reimbursement, validation and workflow integration to justify deployment.
North America and Europe lead clinical use, with South Korea, Japan, China and India expanding through domestic AI companies and hospital digitisation. Competition involves AI pathology specialists, diagnostic and imaging leaders with algorithm marketplaces and precision medicine companies integrating pathology with genomics.
The InsightAce study provides US$ revenue forecasts for every software type, application, deployment and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Powered Digital Pathology Diagnostics Market Snapshot
Chapter 4. Global AI-Powered Digital Pathology Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Software Type Estimates & Trend Analysis
5.1. Software Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Software Type:
5.2.1. Cancer Detection, Grading and Screening Algorithms
5.2.2. Biomarker Quantification and Companion Diagnostic AI
5.2.3. Quality Control, Triage and Workflow Prioritization Tools
5.2.4. Foundation Models and Multimodal Pathology Platforms
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. Application & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
6.2.1. Prostate, Breast and Gastrointestinal Cancer Diagnosis
6.2.2. Immunohistochemistry and Biomarker Scoring
6.2.3. Hematopathology, Cytology and Other Specialties
6.2.4. Drug Development and Clinical Trial Analysis
Chapter 7. Market Segmentation 3: By Deployment Estimates & Trend Analysis
7.1. Deployment & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Deployment:
7.2.1. Cloud-Based
7.2.2. On-Premise and Scanner-Integrated
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Hospitals and Reference Laboratories
8.2.2. Pharmaceutical and Biotechnology Companies
8.2.3. Academic and Research Institutions
Chapter 9. AI-Powered Digital Pathology Diagnostics Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Tempus AI, Inc. (Paige)
11.2. Ibex Medical Analytics Ltd.
11.3. PathAI, Inc.
11.4. Proscia Inc.
11.5. Roche Holding AG (Ventana)
11.6. Philips
11.7. Leica Biosystems (Danaher)
11.8. Hamamatsu Photonics K.K.
11.9. Indica Labs, Inc.
11.10. Mindpeak GmbH
11.11. Aiforia Technologies Plc
11.12. Owkin, Inc.
11.13. Visiopharm A/S
11.14. Deep Bio Inc.
11.15. Lunit Inc.
圖表清單 List of Tables & Figures
Table 1. Global AI-Powered Digital Pathology Diagnostics Market Revenue Forecast by Software Type, 2026-2035 (US$ Mn)
Figure 1. Global AI-Powered Digital Pathology Diagnostics Market Segmentation and Scope Overview
Table 2. Global AI-Powered Digital Pathology Diagnostics Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 2. Global AI-Powered Digital Pathology Diagnostics Market Share by Software Type, 2026 & 2035
Table 3. Global AI-Powered Digital Pathology Diagnostics Market Revenue Forecast by Deployment, 2026-2035 (US$ Mn)
Figure 3. AI Pathology Applications from Cancer Detection to Biomarker Scoring and Foundation Models
Table 4. Global AI-Powered Digital Pathology Diagnostics Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Regulatory Clearances and Clinical Deployments of Pathology AI by Region, 2026
Table 5. Global AI-Powered Digital Pathology Diagnostics Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific AI-Powered Digital Pathology Diagnostics Growth Opportunity Analysis
Table 6. North America AI-Powered Digital Pathology Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key AI-Powered Digital Pathology Diagnostics Market Participants
Table 7. Europe AI-Powered Digital Pathology Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global AI-Powered Digital Pathology Diagnostics Market
Table 8. Asia Pacific AI-Powered Digital Pathology Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Pharmaceutical Use of AI Pathology in Trial Enrichment and Companion Diagnostic Development
Table 9. Strategic Developments of Leading AI-Powered Digital Pathology Diagnostics Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們